229 | India Pesticides IPO Analysis by Arihant Capital Markets Ltd | Arihant Capital Markets Ltd | May apply | IPO |
239 | India Pesticides IPO Analysis by Investmentz Ltd | Investmentz Ltd | May apply | IPO |
255 | G R Infra IPO review | Dilip Davda | May apply | IPO |
261 | G R Infraprojects IPO Analysis by Investmentz Ltd | Investmentz Ltd | May apply | IPO |
277 | Clean Science IPO review | Dilip Davda | May apply | IPO |
293 | Glenmark Life Sciences IPO Analysis by Capital Market | Capital Market | May apply | IPO |
295 | Glenmark Life IPO review | Dilip Davda | May apply | IPO |
301 | Glenmark Life Sciences IPO Analysis by SMC Global | SMC Global | May apply | IPO |
307 | Zomato IPO Analysis by Capital Market | Capital Market | May apply | IPO |
308 | Zomato IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | May apply | IPO |
317 | Tatva Chintan Pharma IPO Analysis by Capital Market | Capital Market | May apply | IPO |
333 | One 97 Commu (PayTM) IPO review | Dilip Davda | May apply | IPO |
341 | Rolex Rings IPO Analysis by Capital Market | Capital Market | May apply | IPO |
349 | Nuvoco IPO Analysis by Arun Kejriwal | Arun Kejriwal | May apply | IPO |
353 | Nuvoco Vistas IPO review | Dilip Davda | May apply | IPO |
363 | Exxaro Tiles IPO Analysis by Arun Kejriwal | Arun Kejriwal | May apply | IPO |
366 | Exxaro Tiles IPO Analysis by Capital Market | Capital Market | May apply | IPO |
367 | Exxaro Tiles IPO review | Dilip Davda | May apply | IPO |
373 | Windlas Bio IPO review | Dilip Davda | May apply | IPO |
382 | Devyani International IPO Analysis by Capital Market | Capital Market | May apply | IPO |
384 | Devyani Intl IPO review | Dilip Davda | May apply | IPO |
398 | CarTrade Tech IPO Analysis by Capital Market | Capital Market | May apply | IPO |
399 | CarTrade Tech IPO review | Dilip Davda | May apply | IPO |
412 | Krsnaa Diagno IPO review | Dilip Davda | May apply | IPO |
420 | Aptus Value Housing Finance IPO Analysis by Capital Market | Capital Market | May apply | IPO |
421 | Aptus Value Housing Finance IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | May apply | IPO |
422 | Aptus Value IPO review | Dilip Davda | May apply | IPO |
431 | Chemplast Sanmar IPO review | Dilip Davda | May apply | IPO |
436 | Ami Organics IPO Analysis by Capital Market | Capital Market | May apply | IPO |
437 | Ami Organics IPO review | Dilip Davda | May apply | IPO |
447 | Vijaya Diagnostic IPO review | Dilip Davda | May apply | IPO |
471 | Aditya Birla Sun Life AMC IPO Analysis by Capital Market | Capital Market | May apply | IPO |
483 | Paras Defence and Space Technologies IPO Analysis by Capital Market | Capital Market | May apply | IPO |
485 | Paras Defence IPO review | Dilip Davda | May apply | IPO |
499 | Fino Payments Bank IPO Analysis by Arun Kejriwal | Arun Kejriwal | May apply | IPO |
503 | Fino Payments IPO review | Dilip Davda | May apply | IPO |
516 | S J S Enterprises IPO review | Dilip Davda | May apply | IPO |
526 | FSN E-Commerce Ventures Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
527 | FSN E-comm (NYKAA) IPO review | Dilip Davda | May apply | IPO |
542 | PB Fintech IPO review | Dilip Davda | May apply | IPO |
549 | Sigachi Industries Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
555 | Sapphire Foods IPO review | Dilip Davda | May apply | IPO |
562 | Tarsons Products Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
572 | Go Fashion (Go Colors) IPO review | Dilip Davda | May apply | IPO |
596 | Tega Industries Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
610 | Anand Rathi Wealth IPO review | Dilip Davda | May apply | IPO |
615 | Anand Rathi IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
620 | C. E. Info Systems IPO review | Dilip Davda | May apply | IPO |
631 | Rategain Travel Technologies Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
632 | Rategain Travel IPO review | Dilip Davda | May apply | IPO |
637 | Data Patterns (India) Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
642 | Data Patterns IPO Analysis by Marwadi Shares and Finance Ltd | Marwadi Shares and Finance Ltd | May apply | IPO |
648 | Shriram Properties IPO review | Dilip Davda | May apply | IPO |
653 | Metro Brands IPO review | Dilip Davda | May apply | IPO |
658 | HP Adhesives IPO review | Dilip Davda | May apply | IPO |
663 | Medplus Health Services Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
664 | MedPlus Health IPO review | Dilip Davda | May apply | IPO |
666 | Medplus Health IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
674 | CMS Info Systems Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
676 | CMS Info Systems IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
122 | Craftsman Automation IPO Analysis by SMC Global | SMC Global | Neutral | IPO |
155 | Barbeque Nation IPO Analysis by Angel One | Angel One | Neutral | IPO |
166 | Barbeque Nation IPO Analysis by SMC Global | SMC Global | Neutral | IPO |
177 | Lodha Developers IPO Analysis by SMC Global | SMC Global | Neutral | IPO |
279 | Clean Science IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
288 | Clean Science IPO Analysis by Sushil Finance Ltd | Sushil Finance Ltd | Neutral | IPO |
292 | Glenmark Life Sciences IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
298 | Glenmark Life Sciences IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
305 | Zomato IPO Analysis by Ambit Capital Pvt Ltd | Ambit Capital Pvt Ltd | Neutral | IPO |
306 | Zomato IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
311 | Zomato IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
313 | Zomato IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
314 | Zomato IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
316 | Tatva Chintan Pharma IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
323 | Tatva Chintan Pharma IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
328 | Paytm IPO Analysis by Ashika Research | Ashika Research | Neutral | IPO |
329 | Paytm IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
330 | Paytm IPO Analysis by Axis Securities Limited | Axis Securities Limited | Neutral | IPO |
332 | One 97 Communications Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
334 | Paytm IPO Analysis by ICICI Direct | ICICI Direct | Neutral | IPO |
336 | Paytm IPO Analysis by Multi-Act Equity Consultancy Pvt Ltd | Multi-Act Equity Consultancy Pvt Ltd | Neutral | IPO |
338 | Paytm IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
340 | Rolex Rings IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
350 | Nuvoco IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
354 | Nuvoco IPO Analysis by Edelweiss Broking Ltd | Edelweiss Broking Ltd | Neutral | IPO |
355 | Nuvoco IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
357 | Nuvoco IPO Analysis by ICICI Direct | ICICI Direct | Neutral | IPO |
364 | Exxaro Tiles IPO Analysis by AUM Capital Ltd | AUM Capital Ltd | Neutral | IPO |
369 | Exxaro Tiles IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
370 | Exxaro Tiles IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
374 | Windlas Biotech IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
379 | Devyani International IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
387 | Devyani International IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
390 | Devyani International IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
391 | Devyani International IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
395 | CarTrade Tech IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
400 | CarTrade Tech IPO Analysis by Edelweiss Broking Ltd | Edelweiss Broking Ltd | Neutral | IPO |
401 | CarTrade Tech IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
405 | CarTrade Tech IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
409 | CarTrade Tech IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Neutral | IPO |
410 | Krsnaa Diagnostics IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
414 | Krsnaa Diagnostics IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
419 | Aptus Value Housing Finance IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
423 | Aptus Value Housing Finance IPO Analysis by Edelweiss Broking Ltd | Edelweiss Broking Ltd | Neutral | IPO |
424 | Aptus Value Housing Finance IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
426 | Aptus Value Housing Finance IPO Analysis by ICICI Direct | ICICI Direct | Neutral | IPO |
427 | Aptus Value Housing Finance IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
428 | Aptus Value Housing Finance IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Neutral | IPO |
429 | Chemplast Sanmar IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
432 | Chemplast Sanmar IPO Analysis by Edelweiss Broking Ltd | Edelweiss Broking Ltd | Neutral | IPO |
435 | Ami Organics IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
439 | Ami Organics IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
442 | Ami Organics IPO Analysis by StockEdge | StockEdge | Neutral | IPO |
445 | Vijaya Diagnostic IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
448 | Vijaya Diagnostic IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
451 | Vijaya Diagnostic IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
452 | Vijaya Diagnostic IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
457 | Vijaya Diagnostic IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
460 | Sansera Engineering IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
465 | Sansera Engineering IPO Analysis by ICICI Direct | ICICI Direct | Neutral | IPO |
466 | Sansera-Engineering IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
467 | Sansera Engineering IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
469 | Sansera-Engineering-Ltd-IPO-Note-Religare-Broking | Religare Broking Limited | Neutral | IPO |
470 | Sansera Engineering IPO Analysis by SMC Global | SMC Global | Neutral | IPO |
473 | Aditya Birla Sun Life AMC IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
474 | Aditya Birla Sun Life AMC IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
476 | Aditya Birla Sun Life AMC IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
480 | Paras Defence and Space Technologies IPO Analysis by Ashika Research | Ashika Research | Neutral | IPO |
481 | Paras Defence and Space Technologies IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
486 | Paras Defence and Space Technologies IPO Analysis by Edelweiss Broking Ltd | Edelweiss Broking Ltd | Neutral | IPO |
488 | Paras Defence and Space Technologies IPO Analysis by ICICI Direct | ICICI Direct | Neutral | IPO |
490 | Paras Defence and Space Technologies IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
492 | Paras Defence and Space Technologies IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
493 | Paras Defence and Space Technologies IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
494 | Paras Defence and Space Technologies IPO Analysis by StockEdge | StockEdge | Neutral | IPO |
497 | Fino Payments Bank IPO Analysis by Angel One | Angel One | Neutral | IPO |
500 | Fino Payments Bank IPO Analysis by Ashika Research | Ashika Research | Neutral | IPO |
501 | Fino Payments Bank IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
502 | Fino Payments Bank Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
504 | Fino Payments Bank IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
506 | Fino Payments Bank IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
509 | Fino Payments Bank IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
510 | Fino Payments Bank IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
513 | SJS Enterprises IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
515 | S.J.S. Enterprises Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
519 | SJS Enterprises IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
521 | SJS Enterprises IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
522 | SJS Enterprises IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Neutral | IPO |
524 | Nykaa IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
529 | Nykaa IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
530 | Nykaa IPO Analysis by IIFL Securities | IIFL Securities | Neutral | IPO |
532 | Nykaa IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
536 | Nykaa IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
541 | PB Fintech Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
543 | PolicyBazaar IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
545 | PolicyBazaar IPO Analysis by ICICI Direct | ICICI Direct | Neutral | IPO |
547 | PolicyBazaar IPO Analysis by Nirmal Bang | Nirmal Bang | Neutral | IPO |
551 | Sigachi Industries IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
553 | Sapphire Foods IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
554 | Sapphire Foods India Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
556 | Sapphire Foods IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
558 | Latent View Analytics Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
560 | Latent View Analytics IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
570 | GoColors IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
571 | Go Fashion (India) Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
574 | GoColors IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
575 | GoColors IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
576 | GoColors IPO Analysis by Reliance Securities | Reliance Securities | Neutral | IPO |
580 | Star Health IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
581 | Star Health IPO Analysis by B & K Securities India Private Ltd. | B & K Securities India Private Ltd. | Neutral | IPO |
582 | Star Health and Allied Insurance Company Ltd IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
585 | Star Health IPO Analysis by Haitong Securities Private Limited | Haitong Securities Private Limited | Neutral | IPO |
586 | Star Health IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
587 | Star Health IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
589 | Star Health IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
593 | Tega Industries IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
595 | Tega Industries IPO Analysis by Canara Bank | Canara Bank | Neutral | IPO |
599 | Tega Industries IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
603 | Tega Industries IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
605 | Tega Industries IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
607 | Anand Rathi IPO Analysis by Ashika Research | Ashika Research | Neutral | IPO |
608 | Anand Rathi IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
612 | Anand Rathi IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
619 | MapmyIndia IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
621 | MapmyIndia IPO Analysis by Haitong Securities Private Limited | Haitong Securities Private Limited | Neutral | IPO |
624 | MapmyIndia IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
630 | RateGain IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
633 | RateGain IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
636 | Data Patterns IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
647 | Shriram Properties Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
651 | Metro Brands IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
652 | Metro Brands Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
657 | HP Adhesives Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
3 | RailTel IPO Analysis by Axis Capital | Axis Capital | Not Rated | IPO |
8 | RailTel IPO Analysis by ICICI Direct | ICICI Direct | Not Rated | IPO |
11 | RailTel IPO Analysis by Kotak Securities | Kotak Securities | Not Rated | IPO |
16 | RailTel IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
17 | IRFC IPO Analysis by Ambit Capital Pvt Ltd | Ambit Capital Pvt Ltd | Not Rated | IPO |
20 | IRFC IPO Analysis by ICICI Direct | ICICI Direct | Not Rated | IPO |
21 | IRFC IPO Analysis by IIFL Wealth | IIFL Wealth | Not Rated | IPO |
First Prev 3 of 4 Next Last |